tiprankstipranks
Trending News
More News >
Iradimed Corp (IRMD)
:IRMD
US Market

Iradimed (IRMD) Income Statement

Compare
174 Followers

Iradimed Income Statement

Last quarter (Q3 2025), Iradimed's total revenue was $21.20M, an increase of 15.69% from the same quarter last year. In Q3, Iradimed's net income was $5.58M. See Iradimed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 73.24M$ 65.56M$ 53.30M$ 41.81M$ 31.72M
Gross Profit
$ 56.35M$ 50.16M$ 41.28M$ 32.05M$ 23.57M
Operating Expenses
$ 34.39M$ 30.12M$ 25.65M$ 22.23M$ 24.33M
Depreciation and Amortization
$ 817.66K$ 765.18K$ 670.67K$ 1.41M$ 1.34M
EBITDA
$ 22.78M$ 20.80M$ 16.30M$ 11.22M$ 582.73K
Operating Income
$ 21.96M$ 20.04M$ 15.63M$ 9.82M$ -756.09K
Other Income/Expenses
$ 2.31M$ 1.70M$ 553.10K$ 18.61K$ 139.21K
Pretax Income
$ 24.28M$ 21.74M$ 16.18M$ 9.84M$ -616.88K
Net Income
$ 19.23M$ 17.19M$ 12.83M$ 9.33M$ 1.37M
Per Share Metrics
Basic EPS
$ 1.52$ 1.36$ 1.02$ 0.76$ 0.11
Diluted EPS
$ 1.50$ 1.35$ 1.02$ 0.74$ 0.11
Weighted Average Shares Outstanding
12.67M 12.60M 12.56M 12.35M 12.12M
Weighted Average Shares Outstanding (Diluted)
12.78M 12.72M 12.64M 12.59M 12.44M
Currency in USD

Iradimed Earnings and Revenue History